OAM
ATRA icon

Oxford Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Oxford Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,363
Closed -$1.39M – 306
2019
Q4 		$1.39M Buy
+3,363
New +$1.16M 0.04% 640
2019
Q1 		– Sell
-615
Closed -$534K – 1653
2018
Q4 		$534K Buy
+615
New +$571K 0.01% 1170
2016
Q1 		– Sell
-4,025
Closed -$2.54M – 794
2015
Q4 		$2.54M Buy
+4,025
New +$3.04M 0.06% 350

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return